BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38492033)

  • 21. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series.
    Cleret de Langavant L; Petit A; Nguyen QTR; Gendre T; Abdelhedi J; Djellaoui A; Seddik L; Lim L; Faugeras F; Salhi H; Wahab A; Fechtenbaum L; Dormeuil A; Hosseini H; Youssov K; Fénelon G; Bapst B; Brugières P; Tuilier T; Kalsoum E; Matignon MB; Oniszczuk J; Gallien S; Vindrios W; Melica G; Scain AL; Esser R; Rostain L; Guillaud C; Dubos-Lascu G; Saada N; Guillet H; Khellaf M; Bardel B; Ayache SS; Lefaucheur JP; Pawlotsky JM; Fourati S; Bachoud-Lévi AC
    Rev Neurol (Paris); 2021 Mar; 177(3):275-282. PubMed ID: 33610347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Community-Acquired Neonatal SARS-CoV-2 Infection Associated with Neurological Symptoms in Colombia.
    Alvarado-Socarras JL; Theurel-Martin D; Cruz-Hernandez M; Rodriguez-Morales AJ
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33823049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.
    Yin R; Feng W; Wang T; Chen G; Wu T; Chen D; Lv T; Xiang D
    J Med Virol; 2020 Oct; 92(10):1782-1784. PubMed ID: 32293714
    [No Abstract]   [Full Text] [Related]  

  • 25. Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection.
    Llach CD; Vieta E
    Eur Neuropsychopharmacol; 2021 Aug; 49():119-121. PubMed ID: 33992951
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
    Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
    Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.
    Amruta N; Chastain WH; Paz M; Solch RJ; Murray-Brown IC; Befeler JB; Gressett TE; Longo MT; Engler-Chiurazzi EB; Bix G
    Cytokine Growth Factor Rev; 2021 Apr; 58():1-15. PubMed ID: 33674185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In patients with neurological complications, SARS-CoV-2 infection must be confirmed by PCR.
    Finsterer J
    Brain Dev; 2024 Feb; 46(2):122-123. PubMed ID: 38057217
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms.
    Neumann B; Schmidbauer ML; Dimitriadis K; Otto S; Knier B; Niesen WD; Hosp JA; Günther A; Lindemann S; Nagy G; Steinberg T; Linker RA; Hemmer B; Bösel J;
    J Neurol Sci; 2020 Nov; 418():117090. PubMed ID: 32805440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological complications of COVID-19: a systematic review.
    Taherifard E; Taherifard E
    Neurol Res; 2020 Nov; 42(11):905-912. PubMed ID: 32698732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological issues in children with COVID-19.
    Lin JE; Asfour A; Sewell TB; Hooe B; Pryce P; Earley C; Shen MY; Kerner-Rossi M; Thakur KT; Vargas WS; Silver WG; Geneslaw AS
    Neurosci Lett; 2021 Jan; 743():135567. PubMed ID: 33352286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long COVID: understanding the neurological effects.
    The Lancet Neurology
    Lancet Neurol; 2021 Apr; 20(4):247. PubMed ID: 33743226
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
    Mussa BM; Srivastava A; Verberne AJM
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential Neurologic Manifestations of COVID-19 Infection in Neonates.
    Rustogi D; Saxena G; Chopra SS; Soraisham A
    Neoreviews; 2024 Feb; 25(2):e71-e77. PubMed ID: 38296786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurological complications of COVID-19: from bridesmaid to bride.
    Nath A; Smith B
    Arq Neuropsiquiatr; 2020 Sep; 78(8):459-460. PubMed ID: 32901698
    [No Abstract]   [Full Text] [Related]  

  • 37. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
    Romoli M; Jelcic I; Bernard-Valnet R; García Azorín D; Mancinelli L; Akhvlediani T; Monaco S; Taba P; Sellner J;
    Eur J Neurol; 2020 Sep; 27(9):1712-1726. PubMed ID: 32503088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
    Iroegbu JD; Ifenatuoha CW; Ijomone OM
    Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.